A Phase I, Randomised, Single-blind Study to Asses the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567 in Healthy Volunteers Using Prednisolone as Positive Control

Trial Profile

A Phase I, Randomised, Single-blind Study to Asses the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567 in Healthy Volunteers Using Prednisolone as Positive Control

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Oct 2017

At a glance

  • Drugs AZD 9567 (Primary) ; Prednisolone
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors AstraZeneca
  • Most Recent Events

    • 17 Oct 2017 Status changed from recruiting to completed.
    • 25 Aug 2017 Planned End Date changed from 4 Sep 2017 to 16 Oct 2017.
    • 25 Aug 2017 Planned primary completion date changed from 4 Sep 2017 to 16 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top